English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

The phase (trans)formation and physical state of a model drug in mesoscopic confinement.

MPS-Authors
/persons/resource/persons206062

Godec,  A.
Research Group of Mathematical Biophysics, MPI for Biophysical Chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)

2473763_Suppl.pdf
(Supplementary material), 2MB

Citation

Ukmar, T., Godec, A., Planinsek, O., Kaucic, V., Mali, G., & Gaberscek, M. (2011). The phase (trans)formation and physical state of a model drug in mesoscopic confinement. Physical Chemistry Chemical Physics, 13(35), 16046-16054. doi:10.1039/c1cp20874h.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-D642-6
Abstract
Compounds embedded into mesoporous or even microporous matrices are interesting for many emerging applications, such as novel catalysts, sensors, batteries, hydrogen storage materials or modern drug delivery devices. We report on two unexpected phenomena regarding the structural and dynamic properties of a model drug substance (indomethacin) when confined in mesoscopic matrices. Firstly, we show that the confinement directs the crystallization of the drug into a stable polymorph that is not otherwise formed at all; its relative amount depends on the pore size. This phenomenon is also explained theoretically using a modified classical heterogeneous nucleation theory. Secondly, we demonstrate that-even at relatively low volume fractions-the confined drug forms a condensed phase in a way that obstructs the passage of the pore channels. This may have far-reaching consequences for understanding the mechanisms of drug release from porous matrices.